Finland· FI-REL-REL5255

Primobolan

A metenolone product, registered in Finland by Schering Oy.

ATC A14AA04

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedPrimobolanATCA14AA04REGISTER NO.FI-REL-REL5255PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Manufacturer
Schering Oy
Country
Finland (FI)
ATC code
A14AA04
ATC class
Metenolone
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under A14AA04

Metenolone, as other registers publish it.

All metenolone products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c38227dd-f2b9-43cf-95d5-5553c2b79919
GET /v1/drugs/c38227dd-f2b9-43cf-95d5-5553c2b79919?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "10",
  "form": "tabletti",
  "route": null,
  "ddd_unit": "mg",
  "strength": "25 mg",
  "atc_label": "metenoloni",
  "ma_number": "6244",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL5255",
  "authorised_at": "1971-07-28"
}

See everything about metenolone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.